PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills

PetMeds and myBalto Host “Top of the Class” Drive to Provide Care for Pets Who Need It Most

DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds^®”) (NASDAQ: PETS) today announced that it partnered with the myBalto Foundation for its recent “Top of the Class” fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs.

“PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding access to care for pets and providing peace of mind for the people who love them,” said Sandra Campos, CEO, PetMeds. “Veterinarians are on the front lines of pet health, and when financial barriers prevent care, everyone loses. Our support of myBalto reflects our belief that no pet should go without the treatment they need–and no vet should have to carry that burden alone.”

In addition to sponsoring the event, PetMeds further supported the "Top of the Class" fundraising drive by offering generous donors 25% off their next purchase, which encouraged community members to join the competition and support their local veterinary clinic.

“Because of companies like PetMeds and individuals who support our work, myBalto has been able to help hundreds of pets live longer and healthier lives,” said Robert Parkins DVM and CEO of myBalto. “With myBalto, we are providing innovative ways for veterinarians to provide critical financial support to their patients, mirroring the life-saving ethos of Balto and his historic journey.”

myBalto's Angel Funds are designed to provide swift, flexible support to pet parents facing financial hardships, enabling them to access the care their pets need when they need it most—often in emergency or life-threatening situations. myBalto was named with inspiration from Balto, the heroic Alaskan sled dog who helped deliver life-saving medication to the children of Nome, Alaska during a diphtheria outbreak in the 1920s.

About PetMeds
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness and the veterinarians who serve them. Through its PETS family of brands, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.

About myBalto
myBalto is a pioneering platform that enables veterinary hospitals to support pets in need through the creation of custom Angel Funds. By offering simple, effective fundraising tools and a unique payment processing solution, myBalto is helping practices reduce the rate of financial euthanasia and provide critical care to animals whose owners may face financial challenges. To learn more, visit www.mybaltofoundation.org.

Forward Looking Statement
This press release may contain “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such forward-looking statements are set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024, filed on June 14, 2024. The Company’s future results may also be impacted by other risk factors listed from time to time in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release and should not be relied upon as representing the Company’s views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements, other than as may be required by law. If the Company does update one or more forward-looking statements, no inference should be made that the Company will make additional updates with respect to those or other forward-looking statements.

Media Contact for PetMeds:
Berns Communications Group
Danielle Poggi
dpoggi@bcg-pr.com

Investor Contact:
Reed Anderson
investor@petmeds.com